Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Convertible Debt (2018 - 2021)

Historic Convertible Debt for INVO Fertility (IVF) over the last 4 years, with Q3 2021 value amounting to $500000.0.

  • INVO Fertility's Convertible Debt fell 1769.83% to $500000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $500000.0, marking a year-over-year decrease of 1769.83%. This contributed to the annual value of $1.7 million for FY2020, which is 42181.81% up from last year.
  • According to the latest figures from Q3 2021, INVO Fertility's Convertible Debt is $500000.0, which was down 1769.83% from $500000.0 recorded in Q2 2021.
  • INVO Fertility's 5-year Convertible Debt high stood at $1.7 million for Q4 2020, and its period low was $54297.0 during Q2 2018.
  • Moreover, its 4-year median value for Convertible Debt was $412892.0 (2019), whereas its average is $502110.6.
  • Per our database at Business Quant, INVO Fertility's Convertible Debt surged by 42181.81% in 2020 and then crashed by 4989.53% in 2021.
  • INVO Fertility's Convertible Debt (Quarter) stood at $130599.0 in 2018, then surged by 149.45% to $325784.0 in 2019, then skyrocketed by 421.82% to $1.7 million in 2020, then tumbled by 70.59% to $500000.0 in 2021.
  • Its last three reported values are $500000.0 in Q3 2021, $500000.0 for Q2 2021, and $500000.0 during Q1 2021.